Treatment of orogastrointestinal candidosis in SCID mice with fluconazole alone or in combination with recombinant granulocyte colony-stimulating factor or interferon-?

References

• Maenza J, Keruly JC, Moore RD, Chaisson R, Merz WG, Gallant JE. Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients. J Infect Dis 1996; 173: 219–225.
   PubMed Web of Science ®Google Scholar
• Dewsnup DH, Stevens DA Efficacy of oral amphotericin B in AIDS patients with thrush clinically resistant to fluconazole. J Med Vet Mycol 1994; 32: 389–393.
   PubMedGoogle Scholar
• American Thoracic Society. Fungal infection in HIV-infected persons. Am J Respir Grit Care Med 1995; 152: 816–822.
   PubMed Web of Science ®Google Scholar
• Stevens DA, Greene SI, Lang OS. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Ran-domized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily. Arch Intern Med 1991; 151: 2458–2464.
   Google Scholar
• Powderly WG. Resistant candidiasis. AIDS Res Hum Retro-viruses 1994; 10: 925–929.
   PubMed Web of Science ®Google Scholar
• Clemons KY, Stevens DA. Treatment of orogastrointestinal candidosis in SCID mice with fluconazole. In: 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Washington DC: American Society for Microbiology, 1997: Abstract/B12.
   Google Scholar
• Bistoni F, Cenci E, Mencacci A, et al. Mucosal and systemic T helper cell function after intragastric colonization of adult mice with Candida albicans. J Infect Dis 1993; 168: 1449–1457.
   PubMedGoogle Scholar
• Balish E, Jensen J, Warner T, Brekke J, Leonard B. Mucosal and disseminated candidiasis in gnotobiotic SCID mice. J Med Vet Mycol 1993; 31: 143–154.
   PubMedGoogle Scholar
• Cantoma MT, Balish E. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect Immun 1990; 58: 1093–1100.
   PubMedGoogle Scholar
• Stevens DA. Combination immunotherapy and antifungal chemotherapy. Clin Infect Dis 1998; 26: 1266–1269.
   PubMed Web of Science ®Google Scholar
• Stevens DA, Walsh TJ, Bistoni F, et al. Cytokines and mycoses. J Med Vet Mycol 1998; 36 (Suppl. 1): 174–182.
   Google Scholar
• Hanson LH, Perlman AM, Clemons KY, Stevens DA. Synergy between cilofungin and amphotericin B in a murine model of candidiasis. Antimicrob Agents Chemother 1991; 35: 1334–1337.
   PubMed Web of Science ®Google Scholar
• Hoeprich PD, Finn PD. Obfuscation of the activity of antifun-gal antibiotics by culture media. J Infect Dis 1972; 16:353–361.
   Google Scholar
• Greenfield RA, Abrams VL, Crawford DL, Kuhls TL. Effect of abrogation of natural killer cell activity on the course of candidiasis induced by intraperitoneal administration and gas-trointestinal candidiasis in mice with severe combined im-munodeficiency. Infect Immun 1993; 61: 2520–2525.
   PubMed Web of Science ®Google Scholar
• Narayanan R, Joyce WA, Greenfield RA Gastrointestinal can-didiasis in a murine model of severe combined immunodefi-ciency syndrome. Infect Immun 1991; 59: 2116–2119.
   PubMedGoogle Scholar
• Polak-Wyss A. Protective effect of human granulocyte colony-stimulating factor (hG-CSF) on Candida infections in normal and immunosuppressed mice. Mycoses 1991; 34: 109–118.
   PubMed Web of Science ®Google Scholar
• Graybill JR, Bocanegre R, Luther M. Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis. Eur J Clin Microbiol Infect Dis 1995; 14: 700–703.
   Google Scholar
• Herbrecht R, Waller J, Koenig H, Moreier P, Letscher V. Synergistic activity of recombinant human granulocyte colony-stimulating factor and amphotericin B against disseminated candidosis in nonneutropenic mice. J Mycol Med 1996; 6: 43–48.
   Google Scholar
• Ponnuvel KM, Rama CP, Menon T. Systemic and gastrointes-tinal candidiasis of infant mice as model for antifungal therapy. Ind J Exp Biol 1993; 31: 450–452.
   Google Scholar
• Kinsman OS, Pitblado K. Candida albicans gastrointestinal colonization and invasion in the mouse: effect of antibacterial dosing, antifungal therapy and immunosuppression. Mycoses 1989; 32: 664–674.
   PubMedGoogle Scholar
• Herrera C, Guentzel MN. Mice with persistent gastrointestinal Candida albicans as a model for antifungal therapy. Antimicrob Agents Chemother 1982; 21: 51–53.
   PubMedGoogle Scholar
• Hector RF, Domer JE. Mammary gland contamination as a means of establishing long-term gastrointestinal colonization of infant mice with Candida albicans. Infect Immun 1982; 38: 788–790.
   PubMedGoogle Scholar
• Field LH, Pope LM, Cole GT, Guentzel MN, Berry U. Persistence and spread of Candida albicans after intragastric inoculation of infant mice. Infect Immun 1981; 31: 783–791.
   Google Scholar
• Hector RF, Domer JE. Control of systemic spread of Candida albicans with ketoconazole in the stomachs of mice treated with cytarabine. J Infect Dis 1983; 147: 946–950.
   PubMedGoogle Scholar
• Sandovsky-Losica H, Barr-Nea L, Segal E Fatal systemic candidiasis of gastrointestinal origin: an experimental model in mice compromised by anti-cancer treatment. J Med Vet Mycol 1992; 30: 219–231.
   PubMedGoogle Scholar
• Cole GT, Saha K, Seshan KR, Lynn KT, Franco M, Wong PK. Retrovirus-induced immunodeficiency in mice exacerbates gastrointestinal candidiasis. Infect Immun 1992; 60: 4168–4178.
   PubMedGoogle Scholar
• Flattery AM, Abruzzo GK, Gill CJ, Smith JG, Bartizal K. New model of oropharyngeal and gastrointestinal colonization by Candida albicans in CD4 + T-cell-deficient mice for evaluation of antifungal agents. Antimicrob Agents Chemother 1996; 40: 1604–1609.
   Google Scholar
• Kullberg B-J, van't Wout JW, Hoogstraten C, van Furth R. Recombinant interferon-7 enhances resistance to acute dissemi-nated Candida albicans infections in mice. J Infect Dis 1993; 168: 436–443.
   Google Scholar
• Natarajan U, Brummer E, Stevens DA. Effect of granulocyte colony-stimulating factor on the candidacidal activity of poly-morphonuclear neutrophils and their collaboration with fluconazole. Antimicrob Agents Chemother 1997; 41: 1575–1578.
   Google Scholar